Scott Thomas Smith
Patrimonio netto: 978 688 $ in data 31/05/2026
Patrimonio netto: 978 688 $ in data 31/05/2026
Attualmente, Scott Thomas Smith occupa la posizione di direttore finanziario e vicepresidente senior di Ascendis Pharma A. In precedenza ha occupato la posizione di Direttore-Healthcare Investment Banking Group presso Wedbush Securities, Inc. e Direttore-Global Healthcare Investment Banking presso Merrill Lynch, Pierce, Fenner & Smith, Inc. Smith si è laureato al Claremont McKenna College e ha conseguito un MBA alla Stanford Graduate School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ASCENDIS PHARMA A/S -.--% | 02/06/2026 | 4.367 ( -.--% ) | 978 688 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ASCENDIS PHARMA A/S | Direttore Finanziario/CFO | 08/08/2016 |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Direttore Finanziario/CFO | 01/08/2016 |
| Società | Posizione | Fine |
|---|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01/01/2016 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Claremont McKenna College
Claremont McKenna College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale